TrialTrials2017

Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trial.

Seerapani Gopaluni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.